Changes in Hong Kong stocks | Jinhai Medical Technology (02225) continued to rise by more than 4%, a record high, and its stock price increased by more than 60% on the fourth day of entering the Stock Exchange

The Zhitong Finance App learned that Jinhai Medical Technology (02225) continued to rise by more than 4%, hitting a new listing high of HK$6.99 in the intraday period. Since it was officially incorporated into the Hong Kong Stock Connect on September 7, the cumulative increase has reached 60%. As of press release, it rose 4.17% to HK$6.745, with a turnover of HK$128 million.

According to the news, since September 7, Jinhai Medical Technology officially entered the Hong Kong Stock Connect list, successfully opening a compliant purchase channel for southbound capital. In the first half of this year, the company achieved revenue of SGD34 million, a sharp increase of 134.16% over the previous year. Losses narrowed sharply during the same period, mainly due to explosive growth in medical device-related businesses. During the period, the share of revenue from minimally invasive surgical solutions, medical products and related service fees climbed to 74.73%. Revenue from this business surged 301.5% year on year to SGD 25.427 million. The company's strategic focus is shifting from traditional business to a high-value-added medical device circuit.